Nutropin Aq Pen is a drug owned by Genentech Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 09, 2015. Details of Nutropin Aq Pen's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5763394 | Human growth hormone aqueous formulation |
Jun, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Nutropin Aq Pen is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Nutropin Aq Pen's family patents as well as insights into ongoing legal events on those patents.
Nutropin Aq Pen's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Nutropin Aq Pen's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 09, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Nutropin Aq Pen Generics:
There are no approved generic versions for Nutropin Aq Pen as of now.
Alternative Brands for Nutropin Aq Pen
There are several other brand drugs using the same active ingredient (Somatropin Recombinant) as Nutropin Aq Pen. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| Emd Serono |
| |||
| Genentech |
| |||
| Novo Nordisk Inc |
| |||
| Pharmacia And Upjohn |
|
About Nutropin Aq Pen
Nutropin Aq Pen is a drug owned by Genentech Inc. Nutropin Aq Pen uses Somatropin Recombinant as an active ingredient. Nutropin Aq Pen was launched by Genentech in 2008.
Approval Date:
Nutropin Aq Pen was approved by FDA for market use on 03 January, 2008.
Active Ingredient:
Nutropin Aq Pen uses Somatropin Recombinant as the active ingredient. Check out other Drugs and Companies using Somatropin Recombinant ingredient
Dosage:
Nutropin Aq Pen is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 10MG/2ML (5MG/ML) | INJECTABLE | Prescription | INJECTION |